139 results
Page 4 of 7
6-K
EX-99.2
i2i2j
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.1
u9heh22 241d635n6
16 Nov 22
XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer
7:29am
424B3
1mbvzmh1ti2 5e
14 Nov 22
Prospectus supplement
1:51pm
6-K
EX-99.2
c6zgbzlq
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
6-K
EX-99.3
5v0kvti8p7sf74
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
6-K
EX-99.4
qhe91hnh dvfe2
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
S-8
EX-4.2
5mcp65z ivw
27 Oct 22
Registration of securities for employees
7:09pm
424B4
ekxmbs
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
ehc1kjajafx
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
eepo57
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1/A
EX-10.14
rjst qj0iraa
9 Sep 22
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.2
mszopgfmtj ezb3x
9 Sep 22
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.3
3zfjntf5
9 Sep 22
Registration statement (foreign) (amended)
9:34pm
F-1
i2oppi m7f47
8 Sep 22
Registration statement (foreign)
1:02pm
UPLOAD
0yo98p 2bysca
16 Aug 22
Letter from SEC
12:00am
DRS
67oo1n lbf
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.3
3111fu1ot3
11 Aug 22
Condensed Interim Consolidated Financial Statements
7:00am
6-K
EX-99.2
9q8srrp
11 Aug 22
Condensed Interim Consolidated Financial Statements
7:00am
6-K
EX-99.4
utsw2 pdnwxpjj6oz8j
11 Aug 22
Condensed Interim Consolidated Financial Statements
7:00am
6-K
EX-99.1
sr8xpzh8rw
19 Jul 22
XORTX Announces Submission to European Medicines Agency
7:00am